Does insulin resistance drive the association between hyperglycemia and cardiovascular risk?

about

Cardiovascular risk stratification and management in pre-diabetes.Insulin resistance: The linchpin between prediabetes and cardiovascular disease.

P2860

Q38205374-137AAC27-DDC0-40D3-9169-240E9533C119 Q40956133-0CF0A3EF-48BA-4383-8F22-884D10722512

P2860

Does insulin resistance drive the association between hyperglycemia and cardiovascular risk?

Item

http://www.wikidata.org/entity/Q28728387

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Does insulin resistance drive ...... cemia and cardiovascular risk?

@ast

Does insulin resistance drive ...... cemia and cardiovascular risk?

@en

Does insulin resistance drive ...... cemia and cardiovascular risk?

@nl

type

Item

label

Does insulin resistance drive ...... cemia and cardiovascular risk?

@ast

Does insulin resistance drive ...... cemia and cardiovascular risk?

@en

Does insulin resistance drive ...... cemia and cardiovascular risk?

@nl

prefLabel

Does insulin resistance drive ...... cemia and cardiovascular risk?

@ast

Does insulin resistance drive ...... cemia and cardiovascular risk?

@en

Does insulin resistance drive ...... cemia and cardiovascular risk?

@nl

P1476

Does insulin resistance drive ...... cemia and cardiovascular risk?

@en

P2093

Leigh Perreault

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and classification of diabetes mellitus

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Effects of intensive glucose lowering in type 2 diabetes

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

10-year follow-up of intensive glucose control in type 2 diabetes

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Glucose control and vascular complications in veterans with type 2 diabetes

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range.

P304

e39260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0039260

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bryan C Bergman

Kristine Færch

P577

2012-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227712724

http://www.w3.org/2001/XMLSchema#string

P698

22720085

http://www.w3.org/2001/XMLSchema#string

P921

hyperglycemia

P932

3376119

http://www.w3.org/2001/XMLSchema#string

Does insulin resistance drive the association between hyperglycemia and cardiovascular risk?

about

P2860

P2860

Does insulin resistance drive the association between hyperglycemia and cardiovascular risk?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932